MustGrow Biologics Corp. (MGRO)
TSX Venture Exchange · Canada · prices in CAD · close of 20 Oct 2026
Key indicators
| Last close | CAD 0.385 |
|---|---|
| 52-week range | 0.290 – 0.940 |
| Return, 1 month / 3 months | −8.3% / +10.0% |
| Return, 1 year / 3 years | −51.9% / −67.9% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 79.2% |
| Worst drawdown (1 year) | -66.1% |
| Average daily value traded | 0.02M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MustGrow Biologics Corp. is an agricultural biotechnology company based in Saskatoon, Saskatchewan, Canada. It develops biological products for crop protection and plant health, centred on a mustard-derived biofumigant that serves as a natural alternative to synthetic soil fumigants. Its products are aimed at growers of high-value crops such as fruits, vegetables and potatoes, as well as at turf and ornamental markets, and the company works with partners to develop and commercialise these treatments.
MustGrow Biologics Corp. trades under the code MGRO on the TSX Venture Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MustGrow Biologics Corp. (MGRO) trades on the TSX Venture Exchange in Canada. It last closed at CAD 0.385 on 20 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 845 of 1,500 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 51.9% and over the last three months it rose 10.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 34 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.0% | ||
| From 52-week high | -57.2% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 10.0% | ||
| 6-month return | -32.5% | ||
| 12-month return, skipping the last month | -47.5% | ||
| Stability (higher is calmer) | 50 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 79.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -66.1% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.02M CAD | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −8.3% |
| 3 months | +10.0% |
| 6 months | −32.5% |
| 1 year | −51.9% |
| 3 years | −67.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 0.427 / 0.507 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.030 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.